The Riyadh Global Medical Biotechnology Summit (RGMBS) 2026 stands as a leading international forum dedicated to positioning biotechnology as a strategic national priority with substantial economic and developmental value.

Scheduled from September 14 to 16, 2026, at the Sofitel Riyadh Hotel & Convention Centre, this high-profile event serves as a pivotal nexus for scientific innovation, capital investment, and cross-border partnerships. Organised under influential patronage, the fourth edition of RGMBS aligns precisely with the objectives of Saudi Vision 2030 and the National Biotechnology Strategy. Moreover, the summit acts as a primary catalyst for accelerating the localisation of bio-based innovations, enhancing domestic manufacturing capabilities, and strengthening the Kingdom’s global competitiveness across high-value healthcare domains. Likewise, the comprehensive three-day agenda gathers a distinguished assembly of government dignitaries, healthcare decision-makers, global pharmaceutical chief executives, pioneering researchers, and venture capitalists. Besides, central themes will explore pioneering developments in cell and gene therapies, advanced vaccine engineering, and the revolutionary integration of artificial intelligence within the life sciences. Through sophisticated panel sessions, keynote addresses, and targeted B2B networking segments, attendees will evaluate localised supply chain frameworks, address international regulatory standards, and map out the future of the global bioeconomy. For global stakeholders, RGMBS 2026 offers unparalleled access to one of the world's fastest-growing medical ecosystems. By fostering direct collaboration between research institutions and industry titans, the summit continues to drive public health solutions and shape the next generation of global biomedical advancements. Read more: Saudi International Halal Expo, 2026